Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recombinant Mouse V-Type Immunoglobulin Domain-Containing Suppressor of T-cell Activation (VSIR), C-His

Cat. No.AP2C846

Product TypeAnimal Proteins

Size

Product Overview

BioVenic's Recombinant Mouse V-Type Immunoglobulin Domain-Containing Suppressor of T-cell Activation (VSIR), C-His is a recombinant protein expressed from Human Cells. Its predicted molecular weight is 33.6 kDa. The purity is>90%.

Specifications

Type Recombinant Protein
Species Mouse
Expression System Human Cells
Purity >90%
Endotoxin < 1.0 EU/μg
Predicted Molecular Weight 33.6 kDa
Physical State Lyophilized
Formulation 0.01 mol/L PBS (pH 7.2) containing 0.2% (w/v) Procline-300.

Target Information

Mouse V-Type Immunoglobulin Domain-Containing Suppressor of T-cell Activation (VSIR) is a protein that inhibits T cell activation. VSIR interacts with its ligand, CD155, to deliver inhibitory signals that regulate T cell responses. This pathway helps prevent excessive T cell activation and autoimmunity. VSIR is part of a complex network of inhibitory signals that control T cell function, offering multiple points for therapeutic intervention.

Protein Mouse V-Type Immunoglobulin Domain-Containing Suppressor of T-cell Activation (VSIR)
Protein Synonym Platelet receptor Gi24; V-set domain-containing immunoregulatory receptor
Gene ID 74048
UniProt ID Q9D659

Shipping and Storage

This product is shipped with ice packs. Lyophilized protein can be stored at -20°C for 1 year. After reconstitution, the protein solution can be stored at 2-8°C for 2-7 days.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

User Note

  1. Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquot the reconstituted solution to minimize freeze-thaw cycles.
Inquiry Basket